Health Care & Life Sciences » Pharmaceuticals | Opiant Pharmaceuticals Inc.

Opiant Pharmaceuticals Inc.

Opiant Pharmaceuticals Inc.
Stock Exchange Other OTC
EPS
$3.77
Market Cap
$53.85 M
Shares Outstanding
4 M
Public Float
3.12 M

Profile

Address
201 Santa Monica Boulevard
Santa Monica California 90401
United States
Employees -
Website http://www.opiant.com
Updated 07/08/2019
Opiant Pharmaceuticals, Inc. is a biopharmaceutical company, which develops pharmaceutical solutions for common addictions and related disorders. The company focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids.

Financials

View All

Michael Jeffrey Sinclair
Chairman
Roger Crystal
President, CEO, Director & Head-Media Relations